Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
19
Number of overlapping holdings
17.1%
% of IXJ's 111 holdings also in FMED
33.9%
% of FMED's 61 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
UNITEDHEALTH GROUP INC | 6.8% | 4.1% | 4.1% |
|
INTUITIVE SURGICAL INC | 2.8% | 4.6% | 2.8% |
|
DANAHER CORP | 2.1% | 3.8% | 2.1% |
|
BOSTON SCIENTIFIC CORP | 2.0% | 6.6% | 2.0% |
|
THERMO FISHER SCIENTIFIC INC | 2.9% | 1.9% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to FMED
|
ELI LILLY & CO | 7.2% |
|
JOHNSON & JOHNSON | 4.9% |
|
ABBVIE INC | 4.4% |
 |
NOVO NORDISK A/S-B | 3.9% |
|
MERCK & CO. INC. | 3.6% |
 |
ASTRAZENECA PLC | 3.0% |
 |
ROCHE HOLDING LTD | 2.9% |
|
NOVARTIS AG | 2.8% |
|
ABBOTT LABORATORIES | 2.8% |
|
UNITEDHEALTH GROUP INC | 2.7% |
IXJ Underweight Relative to FMED
|
BOSTON SCIENTIFIC CORP | -4.7% |
|
INSULET CORP | -4.3% |
 |
ARGENX SE ADR | -3.6% |
|
EXACT SCIENCES CORP | -3.2% |
|
PENUMBRA, INC. | -2.8% |
|
ALNYLAM PHARMACEUTICALS INC | -2.7% |
|
LIFESTANCE HEALTH GROUP, INC. | -2.6% |
|
UCB SA | -2.4% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -2.3% |
|
MASIMO CORPORATION | -2.2% |